SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-207227
Filing Date
2017-06-19
Accepted
2017-06-19 17:21:33
Documents
4
Period of Report
2017-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d389402d8k.htm 8-K 21099
2 EX-1.1 d389402dex11.htm EX-1.1 219615
3 EX-5.1 d389402dex51.htm EX-5.1 5315
4 GRAPHIC g389402g31r66.jpg GRAPHIC 8962
  Complete submission text file 0001193125-17-207227.txt   259792
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 17919266
SIC: 2834 Pharmaceutical Preparations